Feasibility study of carboplatin plus TS-1 combination chemotherapy for completely resected non-small cell lung cancer (ALCSG-1001)
Not Applicable
Recruiting
- Conditions
- completely resected non-small cell lung cancer
- Registration Number
- JPRN-UMIN000003993
- Lead Sponsor
- Respiratory Center, Asahikawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients unable to get treatment of CBDCA or TS-1. 2. Sever allergy. 3. Interstitial pneumonia. 4. Active concomitant neoplasia. 5. uncontrolled heart diseases. 6. Pregnant, lactating women. 7. Sever complications. 8. Inappropriate patients judged by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of treatment accomplishment
- Secondary Outcome Measures
Name Time Method Safety, overall survival, relapse-free survival